Pfizer Inc is the world's largest
research-based biomedical and pharmaceutical company.
Founded in 1849, it is dedicated to better health
and greater access to health care for people and
their valued animals. Its corporate headquarters
are in New York, with major research and development
locations in the United States and England.
Pfizer scientists have produced
innovative breakthroughs in a wide range of research
areas, including depression, erectile dysfunction,
high cholesterol, HIV infection, hypertension,
bacterial infections and systemic fungal infections.
Pfizer Limited (India) is one
of the fastest growing pharmaceutical companies
in India. Globally one of the highest spenders
in pharmaceutical R&D, Pfizer has made clinical
research investments of US $ 15.75 million in
India. A survey has ranked Pfizer as the most
respected MNC pharmaceutical company.
For more information, visit:www.pfizer.com
Merck & Co., Inc. is a
global research-driven pharmaceutical company
dedicated to putting patients first. Established
in 1891, Merck discovers, develops, manufactures
and markets vaccines and medicines to address
unmet medical needs. The company devotes extensive
efforts to increase access to medicines through
far-reaching programmes that not only donate Merck
medicines but also help deliver them to the people
who need them. Merck also publishes unbiased health
information as a not-for-profit service.
MSD Pharmaceuticals Private
Limited is an affiliate of Merck & Co. Inc.,
USA. With global headquarter in New Jersey, USA,
Merck & Co. Inc. The Merck Manufacturing Division
employs more than 12,000 people at locations in
For more information, visit:
Wockhardt is a global, pharmaceutical
and biotechnology company that has grown by leveraging
two powerful trends impacting the world of medicine-globalisation
The company has a market capitalisation
of over US$ 1 billion and an annual turnover of
US$ 650 million.
The company has its headquarters
in India, and has 14 manufacturing plants in India,
UK, Ireland, France and US; subsidiaries in US,
UK, Ireland and France and marketing offices in
Africa, Russia, Central and South East Asia.
Wockhardt's strategies are aligned towards being
a significant player in the emerging global biopharmaceuticals
market. In order to achieve this goal, the company
has set up the Wockhardt biotech park, India's
largest biopharmaceuticals complex, with six dedicated
plants built to international standards.
For more information, visit:
Cadila Pharmaceuticals Ltd.
is one of the largest privately held pharmaceutical
companies in India, headquartered at Ahmedabad,
in the state of Gujarat. Over the last five decades,
it has been developing and manufacturing pharmaceutical
products and selling and distributing these in
over 50 countries around the world. An integrated
healthcare solutions provider with pharmaceutical
product basket, it caters to over 50 therapeutic
areas. The company focuses on providing high quality,
appropriately priced products to its customers
and supports all these with dedicated customer
service. Cadila Pharmaceuticals has a workforce
of more than 4000 employees including over 200
people outside India in forty-nine countries of
Africa, CIS, Japan and USA.
The company has one of the
best research and development (R&D) setups
in India, manned by more than three hundred and
fifty scientists and engineers from various disciplines
including biology, pharmacology, clinical research,
chemistry, toxicology, phytochemistry and different
disciplines of engineering. The company also participates
in public-private partnerships for developing
diagnostic, preventive and curative pharmaceutical
and diagnostic products.
Cadila Pharmaceuticals is the
first Indian company to get investigational new
drug (IND) approval by USFDA for clinical trials
to be conducted in India. Subsequently, the company
has filed four more INDs with USFDA.
For more information,
was incorporated in 1961 and went public in 1973.Ranbaxy
Laboratories Limited, India's largest pharmaceutical
company, headquartered in India, is an integrated,
research based, international pharmaceutical company,
producing a wide range of quality, affordable
generic medicines, trusted by healthcare professionals
and patients across geographies. It is ranked
amongst the top ten generic companies worldwide.
has an expanding international portfolio of affiliates,
joint ventures and representative offices across
the globe with a presence in 23 of the Top 25
pharma markets of the world. Additionally the
Company has a presence in 21 of the 25 EU countries.
Ranbaxy has robust operations in USA, UK, France,
Germany, Russia, India, Brazil and South Africa,
and is strengthening its business in Japan, Italy,
Spain and several other markets in the Asia Pacific.
Dr Reddy's Labs
Dr. Reddy's Laboratories was
founded by Dr Anji Reddy, a entrepreneur-scientist,
in 1984 . Today, the company is Indias second
largest pharmaceutical company and the youngest
among its peer group.
The company has several distinctions
to its credit. Being the first pharmaceutical
company from Asia Pacific (outside Japan) to be
listed on the New York Stock Exchange (on April
11, 2001) is only one among them.
Dr. Reddy's continues its journey,
leveraging on its 'Low Cost, High Intellect' advantage.
It has been constantly foraying into new markets
and new businesses and taking on new challenges
and growing stronger and more capable.
Cadila is one of Indias
most reputed, Research based, Tech savvy pharmaceutical
company, focusing on areas Formulations
(Human & Veterinary), New Drug Discovery,
Novel Drug Delivery, Active Pharmaceutical Ingredients,
Analytical Research, Phytochemistry, Biotechnology,
Plant Tissue Culture, Biosynthesis, Genetic Engineering,
Vaccines, Immunoglobulins the entire gamut
of a True Life Sciences Company.The company's
diversified operations encompass Hospital Disposables
& Instrumentation, Diagnostics, Specialty
Chemicals, Softgel, Pharma Machinery, Telecommunications,
Travel & Leisure.
Cadila Pharmaceuticals is
fast emerging as a true Indian multinational.The
company has their wholly owned subsidiaries, joint
ventures, strategic alliances, contract manufacturing,
own marketing offices in 4 countries and have
significant presence in over 46 countries across
the globe. Their business revolves around the
exports of formulations, bulk actives, hospital
disposables, veterinary formulations and pharmaceutical
Besides a significant presence
in the Americas, CIS Countries, Africa, Central
and South-East Asia, Oceanic Countries, Japan,
Middle East and Europe, the company has offices
in USA, Japan, Kenya, Nigeria, Russia, Kazakhstan
and Ukraine. The International SBU plans to expand
operations to more than 100 countries by 2010.